Developing Methodology for the Creation of Clinical Practice Guidelines for Rare Diseases: A Report from RARE-Bestpractices

RARE-Bestpractices Consortium

Research output: Contribution to journalArticle

5 Downloads (Pure)

Abstract

Rare diseases are a global public health priority; they can cause significant morbidity and mortality, can gravely affect quality of life, and can confer a social and economic burden on families and communities. These conditions are, by their nature, encountered very infrequently by clinicians. Thus, clinical practice guidelines are potentially very helpful in supporting clinical decisions, health policy and resource allocation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system is a structured and transparent approach to developing and presenting summaries of evidence, grading its quality, and then transparently interpreting the available evidence to make recommendations in health care. GRADE has been adopted widely. However, its use in creating guidelines for rare diseases – which are often plagued by a paucity of high quality evidence - has not yet been explored. RARE-Bestpractices is a project to create and populate a platform for sharing best practices for management of rare diseases. A major aim of this project is to ensure that European Union countries have the capacity to produce high quality clinical practice guidelines for rare diseases. On February 12, 2013 at the Istituto Superiore di Sanità, in Rome, Italy, the RARE-Bestpractices group held the first of a series of two workshops to discuss methodology for creating clinical practice guidelines, and explore issues specific to rare diseases. This paper summarizes key results of the first workshop, which focused on exploring how the current GRADE approach might (or might not) work for rare diseases. Avenues for future research are also identified.
Original languageEnglish
Article numbere1058463
Number of pages9
JournalRare Diseases
Volume3
Issue number1
Early online date29 Sep 2015
DOIs
Publication statusPublished - 2015

Fingerprint

Rare Diseases
Practice Guidelines
Education
Health Priorities
Resource Allocation
Health Resources
Practice Management
European Union
Health Policy
Italy
Public Health
Economics
Quality of Life
Guidelines
Morbidity
Delivery of Health Care
Mortality

Keywords

  • clinical practice guideline
  • critical appraisal
  • data quality
  • evidence-based medicine
  • health care quality
  • access, and evaluation
  • rare diseases

Cite this

Developing Methodology for the Creation of Clinical Practice Guidelines for Rare Diseases : A Report from RARE-Bestpractices. / RARE-Bestpractices Consortium.

In: Rare Diseases, Vol. 3, No. 1, e1058463, 2015.

Research output: Contribution to journalArticle

@article{7a7ecd46029b40129e4084e6f1914a62,
title = "Developing Methodology for the Creation of Clinical Practice Guidelines for Rare Diseases: A Report from RARE-Bestpractices",
abstract = "Rare diseases are a global public health priority; they can cause significant morbidity and mortality, can gravely affect quality of life, and can confer a social and economic burden on families and communities. These conditions are, by their nature, encountered very infrequently by clinicians. Thus, clinical practice guidelines are potentially very helpful in supporting clinical decisions, health policy and resource allocation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system is a structured and transparent approach to developing and presenting summaries of evidence, grading its quality, and then transparently interpreting the available evidence to make recommendations in health care. GRADE has been adopted widely. However, its use in creating guidelines for rare diseases – which are often plagued by a paucity of high quality evidence - has not yet been explored. RARE-Bestpractices is a project to create and populate a platform for sharing best practices for management of rare diseases. A major aim of this project is to ensure that European Union countries have the capacity to produce high quality clinical practice guidelines for rare diseases. On February 12, 2013 at the Istituto Superiore di Sanit{\`a}, in Rome, Italy, the RARE-Bestpractices group held the first of a series of two workshops to discuss methodology for creating clinical practice guidelines, and explore issues specific to rare diseases. This paper summarizes key results of the first workshop, which focused on exploring how the current GRADE approach might (or might not) work for rare diseases. Avenues for future research are also identified.",
keywords = "clinical practice guideline, critical appraisal, data quality, evidence-based medicine, health care quality, access, and evaluation, rare diseases",
author = "Menaka Pai and Alfonso Iorio and Joerg Meerpohl and Domenica Taruscio and Pierpaolo Mincarone and Leo, {Carlo Giacomo} and Sabina Saverio and Akl, {Elie A.} and Shaun Treweek and Benjamin Djulbegovic and Holger Schunemann and {RARE-Bestpractices Consortium}",
note = "Date of Acceptance: 29/05/2015 The research leading to these results has received funding from the (FP7/2007–2013), under grant agreement n 305690 (RARE-Bestpractices project). The opinions, presented here reflect only the authors’ views. The European Union is not liable for any, use that may be made of the information contained herein.",
year = "2015",
doi = "10.1080/21675511.2015.1058463",
language = "English",
volume = "3",
journal = "Rare Diseases",
issn = "2167-5511",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Developing Methodology for the Creation of Clinical Practice Guidelines for Rare Diseases

T2 - A Report from RARE-Bestpractices

AU - Pai, Menaka

AU - Iorio, Alfonso

AU - Meerpohl, Joerg

AU - Taruscio, Domenica

AU - Mincarone, Pierpaolo

AU - Leo, Carlo Giacomo

AU - Saverio, Sabina

AU - Akl, Elie A.

AU - Treweek, Shaun

AU - Djulbegovic, Benjamin

AU - Schunemann, Holger

AU - RARE-Bestpractices Consortium

N1 - Date of Acceptance: 29/05/2015 The research leading to these results has received funding from the (FP7/2007–2013), under grant agreement n 305690 (RARE-Bestpractices project). The opinions, presented here reflect only the authors’ views. The European Union is not liable for any, use that may be made of the information contained herein.

PY - 2015

Y1 - 2015

N2 - Rare diseases are a global public health priority; they can cause significant morbidity and mortality, can gravely affect quality of life, and can confer a social and economic burden on families and communities. These conditions are, by their nature, encountered very infrequently by clinicians. Thus, clinical practice guidelines are potentially very helpful in supporting clinical decisions, health policy and resource allocation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system is a structured and transparent approach to developing and presenting summaries of evidence, grading its quality, and then transparently interpreting the available evidence to make recommendations in health care. GRADE has been adopted widely. However, its use in creating guidelines for rare diseases – which are often plagued by a paucity of high quality evidence - has not yet been explored. RARE-Bestpractices is a project to create and populate a platform for sharing best practices for management of rare diseases. A major aim of this project is to ensure that European Union countries have the capacity to produce high quality clinical practice guidelines for rare diseases. On February 12, 2013 at the Istituto Superiore di Sanità, in Rome, Italy, the RARE-Bestpractices group held the first of a series of two workshops to discuss methodology for creating clinical practice guidelines, and explore issues specific to rare diseases. This paper summarizes key results of the first workshop, which focused on exploring how the current GRADE approach might (or might not) work for rare diseases. Avenues for future research are also identified.

AB - Rare diseases are a global public health priority; they can cause significant morbidity and mortality, can gravely affect quality of life, and can confer a social and economic burden on families and communities. These conditions are, by their nature, encountered very infrequently by clinicians. Thus, clinical practice guidelines are potentially very helpful in supporting clinical decisions, health policy and resource allocation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system is a structured and transparent approach to developing and presenting summaries of evidence, grading its quality, and then transparently interpreting the available evidence to make recommendations in health care. GRADE has been adopted widely. However, its use in creating guidelines for rare diseases – which are often plagued by a paucity of high quality evidence - has not yet been explored. RARE-Bestpractices is a project to create and populate a platform for sharing best practices for management of rare diseases. A major aim of this project is to ensure that European Union countries have the capacity to produce high quality clinical practice guidelines for rare diseases. On February 12, 2013 at the Istituto Superiore di Sanità, in Rome, Italy, the RARE-Bestpractices group held the first of a series of two workshops to discuss methodology for creating clinical practice guidelines, and explore issues specific to rare diseases. This paper summarizes key results of the first workshop, which focused on exploring how the current GRADE approach might (or might not) work for rare diseases. Avenues for future research are also identified.

KW - clinical practice guideline

KW - critical appraisal

KW - data quality

KW - evidence-based medicine

KW - health care quality

KW - access, and evaluation

KW - rare diseases

U2 - 10.1080/21675511.2015.1058463

DO - 10.1080/21675511.2015.1058463

M3 - Article

VL - 3

JO - Rare Diseases

JF - Rare Diseases

SN - 2167-5511

IS - 1

M1 - e1058463

ER -